Suk Lee is a highly experienced scientist specializing in Antibody-Drug Conjugates (ADCs) and immuno-oncology. They have a strong background in drug target identification, in vitro/ex vivo target validations, and patient-derived organoid models of bladder and prostate cancer. Suk Lee has held positions at prestigious institutions such as Stanford University, Columbia University Irving Medical Center, and currently works as a Principal Scientist at Asieris Pharmaceuticals.
Sign up to view 0 direct reports
Get started